3.Looking Back on the Evolution of Surgery During My Career as a Surgeon and Beyond the Horizon of the Present
Journal of the Japanese Association of Rural Medicine 2010;58(6):627-634
I would like to look back on my career as a clinical surgeon and discuss the progress of surgical technology and some of the current problems facing surgery. Surgical advancements have been supported by developments in other fields such as anesthesiology, radiology (diagnostic imaging), pharmacology and mechanical engineering. The spread of evidence-based medicine, pre and post-operative patient care improvement, and the reduction of surgical site infection and hospital-acquired infection have also contributed. These advancements added to the progress of surgical procedures and the improvement of surgical outcomes. The transition to minimal invasive surgery such as endoscopic and sentinel node navigation surgery is inevitable along with the progress of science and technology. I would also like to refer to remote-controlled and robotic operations.
4.Current Status and Future Perspectives of Cardioplegic Protection in Cardiac Surgery, Highlighting the Mechanisms of Targeted Cellular Components
Yuji Maruyama ; David J Chambers ; Ryuzo Bessho ; Masahiro Fujii ; Dai Nishina ; Takashi Nitta ; Masami Ochi
Japanese Journal of Cardiovascular Surgery 2014;43(5):239-253
“Depolarized arrest”, induced by hyperkalemic (moderately increased extracellular potassium) cardioplegia is the gold standard to achieve elective temporary cardiac arrest in cardiac surgery. Hyperkalemic cardioplegic solutions provide good myocardial protection, which is relatively safe, and easily and rapidly reversible. However, this technique has detrimental effects associated with ionic imbalance involving sodium and calcium overload of the cardiac cell induced by depolarization of the cell membrane. Hence, the development of an improved cardioplegic solution that enhances myocardial protection is anticipated as an alternative to hyperkalemic cardioplegia. In this review, we assess the suitability and clinical potential of cardioplegic agents to induce “non-depolarized arrest” from the viewpoint of rapid cardiac arrest, myocardial protection, reversibility, and toxicity. “Magnesium cardioplegia” and “esmolol cardioplegia” have been shown to exert superior protection with comparable safety profiles to that of hyperkalemic cardioplegia. These alternative techniques require further examination and investigation to challenge the traditional view that hyperkalemic arrest is best. Endogenous cardioprotective strategies, termed “ischemic preconditioning” and “ischemic postconditioning”, may have a role in cardiac surgery to provide additional protection. The elective nature of cardiac surgery, with the known onset of ischemia and reperfusion, lends it to the potential of these strategies. However, the benefit of preconditioning and postconditioning during cardiac surgery is controversial, particularly in the context of cardioplegia. The clinical application of these strategies is unlikely to become routine during cardiac surgery because of the necessity for repeated aortic crossclamping with consequent potential for embolic events, but offers considerable potential especially if “pharmacological” preconditioning and postconditioning could be established.